Study title: Clinical outcomes of treatment with oral pantoprazole in patients aged 5 to 11 years with symptomatic GERD ; safety and tolerability. Out patient,randomized, double-blind, parallel-group.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Digestive System Diseases | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: PANTOPRAZOLE | |||||
| ATC code: A02BC02 | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: 3001A1-322-US | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |